Passa al contenuto
Merck

The first knockin mouse model of episodic ataxia type 2.

Experimental neurology (2014-08-12)
Samuel J Rose, Lisa H Kriener, Ann K Heinzer, Xueliang Fan, Robert S Raike, Arn M J M van den Maagdenberg, Ellen J Hess
ABSTRACT

Episodic ataxia type 2 (EA2) is an autosomal dominant disorder associated with attacks of ataxia that are typically precipitated by stress, ethanol, caffeine or exercise. EA2 is caused by loss-of-function mutations in the CACNA1A gene, which encodes the α1A subunit of the CaV2.1 voltage-gated Ca(2+) channel. To better understand the pathomechanisms of this disorder in vivo, we created the first genetic animal model of EA2 by engineering a mouse line carrying the EA2-causing c.4486T>G (p.F1406C) missense mutation in the orthologous mouse Cacna1a gene. Mice homozygous for the mutated allele exhibit a ~70% reduction in CaV2.1 current density in Purkinje cells, though surprisingly do not exhibit an overt motor phenotype. Mice hemizygous for the knockin allele (EA2/- mice) did exhibit motor dysfunction measurable by rotarod and pole test. Studies using Cre-flox conditional genetics explored the role of cerebellar Purkinje cells or cerebellar granule cells in the poor motor performance of EA2/- mice and demonstrate that manipulation of either cell type alone did not cause poor motor performance. Thus, it is possible that subtle dysfunction arising from multiple cell types is necessary for the expression of certain ataxia syndromes.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
Tamoxifene, ≥99%
Supelco
Caffeina, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Caffeina, powder, ReagentPlus®
Sigma-Aldrich
Caffeina, anhydrous, 99%, FCC, FG
USP
Caffeina, United States Pharmacopeia (USP) Reference Standard
Supelco
Schmelzpunktstandard 235-237°C, analytical standard
Supelco
Caffeina, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Tamoxifene, analytical standard
Supelco
Caffeina, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
USP
Caffeina, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Caffeina, Sigma Reference Standard, vial of 250 mg
Sigma-Aldrich
Caffeina, meets USP testing specifications, anhydrous
Supelco
Caffeina, traceable to primary standards (LGC)
Sigma-Aldrich
Caffeina, anhydrous, tested according to Ph. Eur.
Caffeina, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Caffeina, BioXtra
Sigma-Aldrich
Nimodipine
Caffeina, European Pharmacopoeia (EP) Reference Standard
Supelco
Nimodipine, Pharmaceutical Secondary Standard; Certified Reference Material
Nimodipine, European Pharmacopoeia (EP) Reference Standard